CAITLYN FRANTZ: Open Payments
NPI 1487181574 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,279 in 71 payments from 21 companies in 2025. Trend: 2023 $2,355 · 2024 $3,065 · 2025 $1,279
Food & beverage: $1,279
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $243 |
| AstraZeneca Pharmaceuticals LP | 6 | $162 |
| ABBVIE INC. | 11 | $150 |
| Lilly USA, LLC | 5 | $97 |
| GlaxoSmithKline, LLC. | 5 | $95 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| Exact Sciences Corporation | 3 | $60 |
| Almatica Pharma LLC | 2 | $48 |
| Corcept Therapeutics | 3 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
Products named: Wegovy, BREZTRI, VRAYLAR, JARDIANCE, Ozempic, SHINGRIX, LOREEV XR, Korlym.
Industry payments across OH — which companies pay providers there.
